Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

Presentation to Annual General Meeting

28 February 201428 November 2012 by Justine Bednorz

Presentation to Annual General Meeting

Categories 2012, ASX Announcements

Commencement of three-month toxicology studies for BIT225

Presentation to Annual General Meeting

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 29 November 2024 Legal Notices and Privacy